article thumbnail

Pulsed field ablation for atrial fibrillation: a comprehensive bibliometric analysis of research trends and emerging Frontiers

Frontiers in Cardiovascular Medicine

Pulsed field ablation (PFA) is an emerging non-thermal technique that is gaining traction due to the ability to selectively target myocardial cells and minimize damage to surrounding tissues. The most productive journals were Europace and the Journal of Interventional Cardiac Electrophysiology.

article thumbnail

Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say

DAIC

Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. Early recurrence of atrial tachyarrhythmia (ERAT) is commonly seen following catheter ablation of AF, with reported incidences of up to 61% in the first three months.

article thumbnail

An approach to fluoroless radiofrequency atrial fibrillation ablation

Frontiers in Cardiovascular Medicine

Additional advantages include providing electrophysiology lab personnel with a lead-free working environment and avoiding radiation exposure for both patients and physicians. The advent of three-dimensional (3D) electro-anatomical mapping has significantly reduced the need for fluoroscopy.

article thumbnail

Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter

DAIC

milla1cf Mon, 01/08/2024 - 14:26 January 8, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced that the first patients have been successfully treated using its Magnetic Interventional Ablation Catheter, MAGiC. Physicians at Vilnius University. Račkauskas.

Ablation 111
article thumbnail

Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

DAIC

Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment. said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. "The

Ablation 111
article thumbnail

Distribution Variance of Focal Atrial Tachycardia Foci and Long‐Term Outcomes After Ablation: Experience From Two Chinese Centers

Journal of Cardiovascular Electrophysiology

Distribution Variance of Focal Atrial Tachycardia Foci and Long-Term Outcomes After Ablation. We aimed to evaluate age differences in foci and factors influencing recurrence after radiofrequency catheter ablation in adult and juvenile patients with FAT. After a mean follow-up of 47.2 months, FAT recurred in 57 patients.

article thumbnail

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S. Circulation.